Neurovascular dysfunction and faulty amyloid β-peptide clearance in Alzheimer disease
- PMID: 23028132
- PMCID: PMC3475405
- DOI: 10.1101/cshperspect.a011452
Neurovascular dysfunction and faulty amyloid β-peptide clearance in Alzheimer disease
Abstract
Neurovascular dysfunction is an integral part of Alzheimer disease (AD). Changes in the brain vascular system may contribute in a significant way to the onset and progression of cognitive decline and the development of a chronic neurodegenerative process associated with accumulation of amyloid β-peptide (Aβ) in brain and cerebral vessels in AD individuals and AD animal models. Here, we review the role of the neurovascular unit and molecular mechanisms in cerebral vascular cells behind the pathogenesis of AD. In particular, we focus on blood-brain barrier (BBB) dysfunction, decreased cerebral blood flow, and impaired vascular clearance of Aβ from brain. The data reviewed here support an essential role of the neurovascular and BBB mechanisms in AD pathogenesis.
Figures
Similar articles
-
Neurovascular mechanisms and blood-brain barrier disorder in Alzheimer's disease.Acta Neuropathol. 2009 Jul;118(1):103-13. doi: 10.1007/s00401-009-0522-3. Epub 2009 Mar 25. Acta Neuropathol. 2009. PMID: 19319544 Free PMC article. Review.
-
Neurovascular defects and faulty amyloid-β vascular clearance in Alzheimer's disease.J Alzheimers Dis. 2013;33 Suppl 1(0 1):S87-100. doi: 10.3233/JAD-2012-129037. J Alzheimers Dis. 2013. PMID: 22751174 Free PMC article. Review.
-
Role of the blood-brain barrier in the pathogenesis of Alzheimer's disease.Curr Alzheimer Res. 2007 Apr;4(2):191-7. doi: 10.2174/156720507780362245. Curr Alzheimer Res. 2007. PMID: 17430246 Review.
-
New therapeutic targets in the neurovascular pathway in Alzheimer's disease.Neurotherapeutics. 2008 Jul;5(3):409-14. doi: 10.1016/j.nurt.2008.05.011. Neurotherapeutics. 2008. PMID: 18625452 Free PMC article. Review.
-
Neurovascular mechanisms of Alzheimer's neurodegeneration.Trends Neurosci. 2005 Apr;28(4):202-8. doi: 10.1016/j.tins.2005.02.001. Trends Neurosci. 2005. PMID: 15808355 Review.
Cited by 83 articles
-
Novel MRI Techniques Identifying Vascular Leak and Paravascular Flow Reduction in Early Alzheimer Disease.Biomedicines. 2020 Jul 20;8(7):228. doi: 10.3390/biomedicines8070228. Biomedicines. 2020. PMID: 32698354 Free PMC article. Review.
-
Interactions between Amyloid-Β Proteins and Human Brain Pericytes: Implications for the Pathobiology of Alzheimer's Disease.J Clin Med. 2020 May 15;9(5):1490. doi: 10.3390/jcm9051490. J Clin Med. 2020. PMID: 32429102 Free PMC article. Review.
-
The Apolipoprotein E ε4 Allele-Dependent Relationship Between Serum Lipid Levels and Cognitive Function: A Population-Based Cross-sectional Study.Front Aging Neurosci. 2020 Mar 13;12:44. doi: 10.3389/fnagi.2020.00044. eCollection 2020. Front Aging Neurosci. 2020. PMID: 32231559 Free PMC article.
-
The Influence of Baseline Alzheimer's Disease Severity on Cognitive Decline and CSF Biomarkers in the NILVAD Trial.Front Neurol. 2020 Mar 6;11:149. doi: 10.3389/fneur.2020.00149. eCollection 2020. Front Neurol. 2020. PMID: 32210906 Free PMC article.
-
Benign Regulation of the Astrocytic Phospholipase A2-Arachidonic Acid Pathway: The Underlying Mechanism of the Beneficial Effects of Manual Acupuncture on CBF.Front Neurosci. 2020 Feb 4;13:1354. doi: 10.3389/fnins.2019.01354. eCollection 2019. Front Neurosci. 2020. PMID: 32174802 Free PMC article.
Publication types
MeSH terms
Substances
Grant support
LinkOut - more resources
-
Full Text Sources
-
Other Literature Sources
-
Medical